Common adverse effects include: Nausea (reported by 30-40% of patients at the 2.4 mg dose) Vomiting Diarrhea Constipation Abdominal pain Decreased appetite These gastrointestinal symptoms are typically most pronounced during dose escalation and often improve with continued treatment
Summary Keywords autologous organ-on-chip, precision medicine, disease modelling, tissue engineering, drug testing Citation Bisconti F, Abreu H, Nguyen TD, Stolfi F, Corbezzolo N, Gigli G, Raineri D, Cappellano G, Polini A, Gervaso F, Chiocchetti A and the FLAMIN-GO Consortium (2025) My cells, my model: immune-competent autologous organ-on-chip systems as a new paradigm in precision medicine
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial
92163214 to X.J., No
'These medicines are transforming obesity treatment and can achieve important weight loss